Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-07-06 00:00:00 ET · period of report 2023-07-03 · accession 0001968202-23-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-07-06 | 2023-07-03 | REGN | RYAN ARTHUR F | Dir | S - Sale | $716.88 | -100 | 18.7K | -0.5% | -$71.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-03 | S | D | 6 | $713.82 | 18,839 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-03 | S | D | 1 | $720.15 | 18,747 | D | — | — | |
| 3 | Common | Common Stock | 2023-07-03 | S | D | 1 | $710.09 | 18,846 | D | — | — | |
| 4 | Common | Common Stock | 2023-07-03 | S | D | 1 | $711.95 | 18,845 | D | — | — | |
| 5 | Common | Common Stock | 2023-07-03 | S | D | 10 | $714.65 | 18,829 | D | — | — | (F2) Represents volume-weighted average price of sales of 10 shares of Company stock on July 3, 2023 at prices ranging from $714.17 to $714.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price. |
| 6 | Common | Common Stock | 2023-07-03 | S | D | 7 | $715.23 | 18,822 | D | — | — | (F3) Represents volume-weighted average price of sales of 7 shares of Company stock on July 3, 2023 at prices ranging from $715.02 to $715.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price. |
| 7 | Common | Common Stock | 2023-07-03 | S | D | 29 | $716.74 | 18,793 | D | — | — | (F4) Represents volume-weighted average price of sales of 29 shares of Company stock on July 3, 2023 at prices ranging from $716.09 to $716.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price. |
| 8 | Common | Common Stock | 2023-07-03 | S | D | 22 | $717.57 | 18,771 | D | — | — | (F5) Represents volume-weighted average price of sales of 22 shares of Company stock on July 3, 2023 at prices ranging from $717.22 to $717.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price. |
| 9 | Common | Common Stock | 2023-07-03 | S | D | 12 | $718.71 | 18,759 | D | — | — | (F6) Represents volume-weighted average price of sales of 12 shares of Company stock on July 3, 2023 at prices ranging from $718.47 to $718.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price. |
| 10 | Common | Common Stock | 2023-07-03 | S | D | 11 | $719.36 | 18,748 | D | — | — | (F7) Represents volume-weighted average price of sales of 11 shares of Company stock on July 3, 2023 at prices ranging from $719.05 to $719.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price. |